selected publications
- Phenotypic and targeted drug discovery in immune therapeutics: challenges, opportunities, and future directions. RSC advances. 2025 Review GET IT
- Discovery and Optimization of LAG-3-Targeted Small Molecules via DNA-Encoded Chemical Library (DEL) Screening for Cancer Immunotherapy. Journal of medicinal chemistry. 2025 Academic Article GET IT
- Orthogonal Temperature-Related Intensity Change (TRIC) and TR-FRET as a High-Throughput Screening Platform for the Discovery of SLIT2 Binders: A Proof-of-Concept Approach. SLAS discovery : advancing life sciences R & D. 2025 Academic Article GET IT
- TRIC Coupled with TR-FRET as a High-Throughput Screening Platform for the Discovery of SLIT2 Binders: A Proof-of-Concept Approach. 2025 GET IT
- Discovery of a First-in-Class SLIT2 Binder Disrupting the SLIT2/ROBO1 Axis via DNA-Encoded Library (DEL) Screening. 2025 GET IT
- Stabilization of GTSE1 by cyclin D1-CDK4/6-mediated phosphorylation promotes cell proliferation with implications for cancer prognosis. eLife. 2025 Academic Article GET IT
- Stabilization of GTSE1 by cyclin D1-CDK4/6-mediated phosphorylation promotes cell proliferation: relevance in cancer prognosis. 2025 GET IT
-
Visualizing Single-Stranded DNA Foci in the G1 Phase of the Cell Cycle.
Journal of visualized experiments : JoVE.
2023
Academic Article
GET IT
Times cited: 2 -
A non-natural nucleotide uses a specific pocket to selectively inhibit telomerase activity.
PLoS biology.
2019
Academic Article
GET IT
Times cited: 22 -
Role of Molecular Recognition in l-Cystine Crystal Growth Inhibition.
Crystal growth & design.
2017
Academic Article
GET IT
Times cited: 36